Careteq confirms continued quotation
Open PDF
| Stock | Careteq Ltd (CTQ.ASX) |
|---|---|
| Release Time | 23 Jul 2026, 9:03 a.m. |
| Price Sensitive | Yes |
This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA.
The summaries are generated by large language models so please interpret with care.
Careteq Continues ASX Quotation After EHS Disposal
Key Points
- Careteq confirms continued ASX quotation following EHS Disposal
- HMR Referrals is Careteq's sole operating business
- Positive net operating cash flow of $14k for March quarter
Full Summary
Careteq Limited (ASX: CTQ) announced that ASX confirmed its continued quotation following the divestment of Embedded Health Solutions (EHS). The company's sole operating business is now HMR Referrals, a platform connecting GPs with pharmacists for Home Medicines Reviews. Careteq reported positive net operating cash flow of $14k for the March quarter and plans to strengthen its market position through network growth and strategic initiatives. The company's strategic direction includes deepening network engagement, productising clinic activation, and evaluating adjacent programs and complementary opportunities. Careteq's proposed use of available funds will support growth investments in HMR Referrals.
Sign in to get more information about the company, including guidance changes and other insights.
Sign In